TRANSGENE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.244 EUR | +1.97% |
|
-2.81% | -9.20% |
| 04-10 | Transgene: presents vaccine results at AACR | CF |
| 03-28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRANSGENE | Bio Therapeutic Drugs | +1.97% | -2.81% | -9.20% | -30.27% | -61.84% | 131M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- TNG Stock
- Charts Transgene
- Comparison Chart
